Analisis Keuangan Saham PREV - PreveCeutical Medical Inc. (CNSX) Stock

PreveCeutical Medical Inc.
CA ˙ CNSX ˙ CA74141E1043
Gambaran Umum
PreveCeutical Medical Inc., based in Canada, primarily operates within the healthcare sector, focusing on the development of innovative preventive therapies. The company leverages cutting-edge techniques in medicinal chemistry and biology to create products aimed at preventing ailments rather than merely treating symptoms. Key projects include the development of nature-identical cannabinoids and a peptide-based nasal spray designed to prevent the onset of COVID-19 and other respiratory viruses. This initiative reflects PreveCeutical's strategy of integrating both natural compounds and advanced scientific methods to innovate within the preventive medicine landscape, ultimately aiming to address significant unmet medical needs. Through such projects, PreveCeutical Medical Inc. seeks to establish a prominent role in the global healthcare market by advancing preventive medical solutions.
Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
  • Nilai operating income untuk PreveCeutical Medical Inc. per 2025 Jun 30 adalah -2.21 MM.
  • Nilai net income untuk PreveCeutical Medical Inc. per 2025 Jun 30 adalah -2.60 MM.
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
2025-06-30 -2.21 -2.60
2025-03-31 -1.29 -1.70
2024-12-31 -0.75 -1.17
2024-09-30 -0.95 -1.36
2024-06-30 -0.87 -1.26
2024-03-31 -0.76 -1.13
2023-09-30 -0.83 -0.52
2023-06-30 -1.17 -1.08
2023-03-31 -1.17 -1.26
2022-12-31 -1.04 -1.48
2022-09-30 -1.06 -2.28
2022-06-30 -0.48 -1.48
2022-03-31 -0.64 -1.83
2021-12-31 -0.83 -1.73
2021-09-30 -2.09 -2.90
2021-06-30 -1.75 -2.45
2021-03-31 -2.17 -3.78
2020-12-31 -2.09 -3.80
2020-09-30 0.00 -0.73 -2.23
2020-06-30
Laporan Laba Rugi: EPS
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31
2024-09-30 -0.00 -0.00
2024-06-30 -0.00 -0.00
2024-03-31
2023-09-30 -0.00 -0.00
2023-06-30 -0.00 -0.00
2023-03-31 -0.00 -0.00
2022-12-31 -0.00
2022-09-30 -0.00 -0.00
2022-06-30 -0.00 -0.00
2022-03-31 -0.00 -0.00
2021-12-31 -0.00
2021-09-30 -0.01 -0.01
2021-06-30 -0.00 -0.00
2021-03-31 -0.01 -0.01
2020-12-31 -0.01 -0.01
2020-09-30 -0.01 -0.01
2020-06-30 -0.01 -0.01
Arus Kas: Operasi, Investasi, Pendanaan
  • Nilai cash from operating activities untuk PreveCeutical Medical Inc. per 2025 Jun 30 adalah -0.84 MM.
  • Nilai cash from investing activities untuk PreveCeutical Medical Inc. per 2025 Jun 30 adalah -0.06 MM.
  • Nilai kas dari aktivitas pendanaan untuk PreveCeutical Medical Inc. per 2025 Jun 30 adalah 0.91 MM.
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
2025-06-30 -0.84 -0.06 0.91
2025-03-31 -0.47 -0.06 0.54
2024-12-31 -0.43 -0.00 0.49
2024-09-30 -0.40 -0.00 0.40
2024-06-30 -0.33 -0.00 0.34
2024-03-31 -0.26 0.00 0.25
2023-09-30 -0.03 0.00 0.35
2023-06-30 -0.03 0.00 0.35
2023-03-31 -0.08 -0.00 0.24
2022-12-31 -0.22 0.00 0.21
2022-09-30 -0.45 -0.05 0.12
2022-06-30 -0.17 -0.05 0.09
2022-03-31 -0.69 -0.05 0.10
2021-12-31 -0.43 -0.05 0.14
2021-09-30 -0.55 0.02 0.18
2021-06-30 -0.26 -0.00 0.32
2021-03-31 0.18 -0.00 0.33
2020-12-31 0.06 -0.00 0.18
2020-09-30 0.29 -0.02 0.03
2020-06-30
Metrik Penilaian: PE, PriceToBook, PriceToTBV
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) EBIT/EV EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
Efektivitas Manajemen
  • roa untuk PreveCeutical Medical Inc. pada 2025 Jun 30 adalah -9.60.
Period End (TTM) ROA ROE ROIC (Tingkat Pengembalian Investasi Modal) CROIC OCROIC
2025-06-30 -9.60
2025-03-31 -6.48
2024-12-31 -6.48
2024-09-30 -6.02
2024-06-30 -3.10
2024-03-31 -2.74
2023-09-30 -7.68
2023-06-30 -10.58
2023-03-31 -14.85
2022-12-31 -9.27
2022-09-30 -6.03
2022-06-30 -16.35
2022-03-31 -13.06
2021-12-31 -9.59
2021-09-30 -5.36
2021-06-30 -7.34
2021-03-31 -5.70
2020-12-31 -4.43
2020-09-30 -1.64 -7.70 0.69 0.99
2020-06-30 -1.88
Gross Margins
Margin Kotor
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Margin Keuntungan Bersih
Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
Margin Operasi
Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) Margin Kotor Margin Keuntungan Bersih Margin Operasi
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK)
Grupong Pang-industriya
Other Listings
US:PRVCF
DE:18H € 0.02
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista